Tuesday, June 9, 2026 9:00 AM to 5:00 PM
Shareholder and Co-Chair of the Corporate, Health and Cannabis Law Teams, Michael F. Schaff will serve as a moderator at the New Jersey State Bar Association’s 8th Annual Cannabis and Psychedelics Law Symposium on June 9, 2026, at the New Jersey Law Center in New Brunswick and online.
The symposium, New Jersey’s premier program on cannabis and psychedelics law, will bring together leading practitioners and industry professionals to examine the rapidly evolving legal and regulatory landscape surrounding these emerging areas.
The program will cover key topics including federal and state cannabis policy developments, licensing and compliance challenges, hemp-derived products and THC beverages, municipal regulation and zoning issues, psychedelics legislation and clinical considerations, and the ongoing impact of legalization on criminal law and expungement.
For more information about the program, visit the event page.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.
Michael F. Schaff
Co-Chair, Corporate, Health and Cannabis Law Teams
Shareholder
